{
  "paper_metadata": {
    "pmid": "33546753",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR gene variant V142I, including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 34,
        "demographics": "Predominantly African American/African or Hispanic/Latinx",
        "phenotype": "Hereditary transthyretin amyloidosis (hATTR)"
      },
      "penetrance_data": {
        "total_carriers_observed": 34,
        "affected_count": 3,
        "unaffected_count": 31,
        "uncertain_count": null,
        "penetrance_percentage": 8.8,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Hereditary transthyretin amyloidosis",
          "evidence_sentence": "Notably, the individual with a prior diagnosis of hATTR was the only EA individual to receive a TTR result and the only individual not harboring V142I."
        },
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms reported",
          "evidence_sentence": "Three of 34 (8.8%) TTR results were disclosed with a third-party Spanish interpreter to participants whose preferred language was Spanish."
        }
      ],
      "functional_data": {
        "summary": "The V142I variant is associated with hereditary transthyretin amyloidosis, particularly in African ancestry populations.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The variant segregates with disease in families, as indicated by the affected status of some carriers.",
      "population_frequency": "Common in African ancestry populations",
      "evidence_level": "Strong evidence based on clinical significance and population studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The study highlights the importance of including TTR in genomic screening programs for diverse populations.",
      "key_quotes": [
        "The addition of TTR to a pilot genomic screening program meant that we returned results to a higher proportion of AA and HL participants.",
        "Three of 34 (8.8%) TTR results were disclosed with a third-party Spanish interpreter to participants whose preferred language was Spanish."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text, focusing on the TTR gene."
  }
}